As we enter the next stage of this pandemic, with many states beginning phased re-openings and hospitals preparing to resume elective procedures, we have the opportunity to reflect on our experiences and consider how what we have learned so far can help us plan for a possible second wave of the novel coronavirus.
To help the nation’s hospitals prepare, we sourced best practices from pharmacy leaders across the country who have experienced COVID-19 surges. We hope that these learnings will provide practical guidance for health systems on how to incorporate the pharmacy into their broader strategic plans.
Expand medication intelligence for improved decision-making
With the anticipated, continued demand for medications to treat COVID-19 (not to mention new medication demands as medical and surgical procedures ramp back up), health systems will need to pay close attention to their medication inventory.
Many hospitals experienced drug shortages and supply chain disruptions during the first wave of COVID-19 surges. To avoid these issues during a second wave, pharmacists must have clearer visibility into inventory. This will give them the ability to proactively identify inventory challenges and plan accordingly.
We know how difficult it can be to make decisions about deploying medications during these critical times. That’s why we partnered with two leading healthcare organizations, the American Society of Hospital Pharmacists and the Society of Critical Care Medicine, to identify and track more than 75 of the most commonly used medications for COVID-19 treatment. This intelligence will help hospitals make better, faster decisions around medication allocation and allow them to calculate what may be needed in a future surge.
Here’s an additional note on medication management. Using automated pharmacy technology like that developed by my company can help hospitals take the insights discussed above one step further by providing granular intelligence right at the point-of-care. Pharmacy leaders in surge areas told us that the level of visibility and specificity into inventory provided by automated dispensing cabinets further empowered them to implement safeguards on critical medications, project, plan, and mitigate shortages, and increase emergency care levels as needs shifted.
Adapt staff roles and workflows to accommodate new realities
This pandemic has required all staff to reconsider their typical roles and ways of working, including pharmacy staff. Many hospitals have expanded the pharmacist’s role as part of their efforts to manage this crisis. Whether it’s cross-training staff on pharmacy operations, implementing new shift models for surges, employing telehealth to interact with patients, or looking to pharmacy residents to fill staffing gaps (in some cases, they’ve even fast-tracked to graduation to support COVID-19 efforts), pharmacy practices are changing.
Beyond these small but not minor changes, the very role of the pharmacist is being reconsidered during this pandemic. Pharmacists, who are one of the most underutilized healthcare workers in the system, see an opportunity to contribute more directly to patient care during this time.
Pharmacists should always be able to perform at the top of their license. But in times of crisis, like this pandemic, they continue to raise their hands and find ways to support critical patient care needs.
Automate medication-related tasks to mitigate risk
Because pharmacists are so bogged down by administrative work, many health systems have looked to automation to free them up for tasks that are more central to patient care, directly impact medication outcomes and costs, and that reduce the overall number of medication errors. Studies show that having pharmacists deal directly with patients also improves satisfaction - and ultimately boosts bottom lines.
While by no means comprehensive, we believe that these pharmacy best practices around expanding pharmacy supply chain intelligence, adapting staff roles and workflows, and automating pharmacy tasks can go a long way toward helping health systems prepare for the next phase of this pandemic.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More
2 Commerce Drive
Cranbury, NJ 08512